发明名称 METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION
摘要 The present invention describes an association between genetic polymorphisms in the ABCC2 gene and a predisposition to prolongation of the QT interval, and provides related methods for the prediction of such a predisposition, the administration of QT interval-prolonging compounds to individuals having such a predisposition, and determining whether a compound is capable of inducing QT prolongation.
申请公布号 US2015225794(A1) 申请公布日期 2015.08.13
申请号 US201514694141 申请日期 2015.04.23
申请人 Vanda Pharmaceuticals, Inc. 发明人 Lavedan Christian;Volpi Simona;Licamele Louis
分类号 C12Q1/68;C07D413/04 主分类号 C12Q1/68
代理机构 代理人
主权项 1. A method of administering to an individual a compound capable of prolonging the individual's QT interval, the method comprising: determining at least a portion of an individual's ABCC2 gene sequence; and in the case that a portion of the individual's ABCC2 gene sequence is associated with an increased risk of QT prolongation, administering to the individual a quantity of the compound less than would be administered to an individual having a ABCC2 gene sequence not associated with an increased risk of QT prolongation.
地址 Washington DC US